Fujian Aonong Biological T trades 0 percent unchanged on Tuesday 27th of October
Fujian Aonong Biological T faces revenue decline and widening losses amid restructuring plans, while investors watch its cash‑tied debt and legal disputes closely.
3 minutes to read